OpenAI Makes ChatGPT Health Available to All US Users
OpenAI Expands ChatGPT Health to All US Users Amid Safety Concerns
OpenAI has officially launched ChatGPT Health for all adult users across the United States, marking a significant expansion of its consumer health information service. The feature, which began testing in January, enables users to receive personalized health-related responses by integrating data from Apple Health, Epic Systems, MyFitnessPal, and other platforms.
 |
| Credit: Jakub Porzycki/NurPhoto / Getty Images |
What the ChatGPT Health Expansion Actually Means for Users
Previously, users needed to access a dedicated health hub for health-related queries. Now, OpenAI has integrated these capabilities directly into the general chat experience. The company found that approximately 70% of health-related questions were being asked outside the dedicated hub during testing, suggesting that users naturally gravitate toward asking about health in their everyday conversations.
The new integration allows ChatGPT to draw from connected health information across all queries. For example, a user could ask about meal options and have the system reference their dietary data from MyFitnessPal, or discuss exercise recommendations while incorporating activity metrics from Apple Health.
OpenAI reports that weekly health-related queries have grown from 230 million during the initial testing phase to 300 million today. This surge reflects both the growing public appetite for AI-powered health information and the increasing integration of these tools into daily life.
The Lawsuit That Overshadows the Launch
The timing of this broader release is impossible to separate from the legal challenge OpenAI now faces. The Florida pastor's lawsuit centers on an incident where ChatGPT reportedly advised against consulting a physician in what the plaintiff describes as a near-fatal recommendation.
OpenAI has responded by pointing to its terms of service, which explicitly state that its services are "not intended for use in the diagnosis or treatment of any health condition." The company also told The New York Times that it continues working to improve the safety of health-related responses.
This lawsuit highlights the fundamental tension in AI health services. While companies like OpenAI, Anthropic, and Google race to offer increasingly sophisticated health features, they simultaneously maintain legal disclaimers designed to shield them from liability. The gap between what these tools can technically do and what they should responsibly do remains substantial.
Behind the Technology: What Makes ChatGPT Health Different?
OpenAI claims significant technical progress in health-related query handling. The company notes that GPT-5.6-Luna, its smallest new model, outperforms GPT-5.5 on HealthBench, an open-source benchmark OpenAI developed specifically to evaluate large language models on health queries. This suggests performance improvements even in more compact, efficient model versions.
The company emphasizes that user data is not used for model training, addressing privacy concerns that inevitably accompany health information sharing. OpenAI also collaborates with physicians to refine its models' responses to medical queries, though the specifics of this physician involvement remain somewhat vague.
However, the company's own HealthBench benchmark raises questions. Because OpenAI developed the benchmark internally, evaluating its models against it creates an inherent conflict of interest. Independent third-party evaluations would provide more meaningful safety assessments.
The Broader AI Health Industry: A Competitive Race With Safety Questions
OpenAI is far from alone in pursuing health applications. Anthropic and Google have launched their own health-related AI features, recognizing the enormous market potential. The numbers speak for themselves—300 million weekly health queries represent a massive engagement opportunity.
Yet multiple independent studies have repeatedly demonstrated that current AI systems are not reliable sources for medical advice. These findings have not slowed industry momentum, suggesting that companies are betting on rapid improvement or are willing to accept the liability risks in exchange for market position.
The lack of regulatory clarity complicates matters further. The FDA has not established clear guidelines for AI health information tools that stop short of medical device classification. This regulatory gap allows companies to operate in a gray area, offering health information without the oversight applied to traditional medical software.
Why This Matters: The Practical Implications for Users
For the average US user, ChatGPT Health offers a more personalized and convenient way to access health information. Someone tracking their nutrition through MyFitnessPal can now ask ChatGPT about meal suggestions that account for their logged data. A user syncing Apple Health data might receive more contextualized exercise recommendations.
However, the service includes significant limitations. OpenAI explicitly instructs users to verify information and base medical decisions on professional advice. The company's disclaimers remain prominently visible, suggesting that while the technology has advanced, it has not reached a point where it can be trusted independently.
A Critical Question: Can AI Health Tools Earn Trust Despite Legal Disclaimers?
The most significant tension in this rollout is OpenAI's attempt to position ChatGPT Health as a valuable tool while simultaneously insulating itself from liability. The company cannot have it both ways indefinitely. If the technology genuinely provides valuable health guidance, users will naturally treat its recommendations as medical advice regardless of disclaimers. If it consistently requires verification, its practical utility becomes questionable.
The lawsuit against OpenAI demonstrates this contradiction in real-world consequences. While the company's terms of service may provide legal protection, they do not address the fundamental problem: when users ask health questions, they are inherently seeking guidance they can act upon.
OpenAI's approach to this tension—relying on disclaimers while continuing to expand functionality—may prove unsustainable. Competitors face the same challenge, but OpenAI's market leadership means its handling of this issue will likely influence regulatory and consumer expectations for the entire industry.
What Happens Next
ChatGPT Health is rolling out this week to all logged-in US users across free, Go, Plus, and Pro plans on both web and iOS. The company has signaled its commitment to the health space despite the legal challenges it now faces.
The broader implications extend beyond OpenAI alone. This expansion represents another step toward AI systems that integrate deeply with personal data, particularly sensitive health information. The safety and liability questions raised by this rollout will likely intensify as more users adopt the feature and as more incidents—or potential incidents—come to light.
Regulatory attention seems inevitable. Whether through FDA guidance, congressional action, or litigation outcomes, the legal framework around AI health information will almost certainly evolve in response to products like ChatGPT Health. The question is whether that evolution will occur through proactive regulation or reactive crisis management.
For now, OpenAI is betting that users will welcome the convenience and improved personalization of ChatGPT Health, even as the company acknowledges that its recommendations should not be the final word on anyone's health decisions. That bet may prove correct in the short term, but the long-term success of AI health tools depends on whether the technology can genuinely earn trust—or whether it will remain trapped between its potential and its limitations.
تعليقات
إرسال تعليق